Invasive Hemodynamic Changes Associated With Sodium‐Glucose Cotransporter‐2 Inhibitors: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
Cardiovascular Therapeutics · 2024-01 · 2024 (1)
DOI: 10.1155/2024/2735577 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Cardiovascular Therapeutics, online erschienen am 27.05.2024. Verfasst von Abiodun Idowu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine Einstein Medical Center, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Randomized Controlled Trials as Topic, Hemodynamics, Heart Failure. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Sodium‐glucose cotransporter‐2 inhibitors (SGLT2is) have been shown to lower incident heart failure (HF) and HF hospitalizations, but the mechanisms of benefit in relation to invasive hemodynamics remain unclear. Using PRISMA guidelines, we systematically reviewed multiple online databases for randomized trials evaluating the effect of SGLT2i on invasive hemodynamics. Rest and peak exercise invasive hemodynamics were measured via right heart catheterization pre‐ and postintervention. Random effects model meta‐analysis at a 95% confidence interval was done using RevMan 5.0. A total of 3 studies with a total of 145 patients were included in the meta‐analysis. SGLT2i was significantly associated with a reduction in pulmonary capillary wedge pressure at rest and peak exercise. Similarly, SGLT2i reduced mean pulmonary artery pressure at rest and peak exercise, respectively; however, this was not statistically significant. This hypothesis‐generating study offers mechanistic insights into the central hemodynamic effects of SGLT2i underpinning the HF benefits of SGLT2i.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine Einstein Medical Center, Philadelphia, Pennsylvania, USA.
- Department of Medicine New York Medical College Metropolitan Hospital Center, New York City, New York, USA.
- Department of Medicine St. Luke's Hospital, Chesterfield, Missouri, USA.
- Department of Cardiology Brigham and Women's Hospital, Boston, Massachusetts, USA.
- Division of Nephrology George Washington University School of Medicine, Washington, DC, USA.
- Division of Nephrology Veterans Affairs Medical Center, Washington, DC, USA.
ORCID-Profile: Abiodun Idowu
Zitieren
APA
Idowu, A., Adebolu, O., Bruce, C., Nriagu, B., Evbayekha, E., Lo, K. B., Afolabi-Brown, O., & Rangaswami, J. (2024). Invasive Hemodynamic Changes Associated With Sodium‐Glucose Cotransporter‐2 Inhibitors: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials. Cardiovascular Therapeutics, 2024(1). https://doi.org/10.1155/2024/2735577
Vancouver
Idowu A, Adebolu O, Bruce C, Nriagu B, Evbayekha E, Lo KB, et al. Invasive Hemodynamic Changes Associated With Sodium‐Glucose Cotransporter‐2 Inhibitors: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials. Cardiovascular Therapeutics. 2024;2024(1). doi:10.1155/2024/2735577
BibTeX
@article{Idowu2024,
author = {Idowu, Abiodun and Adebolu, Olayinka and Bruce, Casipit and Nriagu, Bede and Evbayekha, Endurance and Lo, Kevin Bryan and Afolabi-Brown, Olayinka and Rangaswami, Janani},
title = {Invasive Hemodynamic Changes Associated With Sodium‐Glucose Cotransporter‐2 Inhibitors: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials},
journal = {Cardiovascular Therapeutics},
year = {2024},
volume = {2024},
number = {1},
doi = {10.1155/2024/2735577}
}
EUVIMED